Replies to post #214268 on Biotech Values

[DewDiligence]

Mindless musings on MON:

https://finance.yahoo.com/news/time-sell-monsanto-company-nyse-104008286.html

The author apparently doesn’t realize that Bayer is acquiring MON for $128/sh in cash (subject to approval by antitrust regulators).

[DewDiligence]

MON must be confident that the Bayer merger will close soon—they are forgoing a CC for the FY2Q18 earnings release next week:

https://finance.yahoo.com/news/monsanto-company-release-second-quarter-220600907.html

No conference call is scheduled in light of the pending merger with Bayer.